TECNIS IOL ZCT400 (REF ZCT400U160)Recalls & reported problems
Johnson & Johnson Surgical Vision, Inc. · TECNIS TORIC 1-PIECE 6.0MM 16.0D CYL4.00 · Class 3 · Implant
All models of TECNIS IOL (1344)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 3
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 05050474553835), received between Jul 17, 2018 and Aug 27, 2020 — classified as 3 injuries.
The most frequently reported specific device problem is “Unintended Movement” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem2
- Unintended Movement1
Patient problems
- No Code Available2
- Blurred Vision1
- Therapeutic Effects, Unexpected1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
InjuryAug 27, 2020Unintended Movement; Unintended Movement
IT WAS REPORTED THAT AN INTRAOCULAR LENS (IOL) IN THE PATIENT'S RIGHT EYE IS PLANNED TO BE EXPLANTED SOON AS IT ROTATED 45 DEGREES FROM ITS ORIGINAL POSITION. THE PATIENT HAS BLURRY VISION, UNCORRECTED VISION WAS ABOUT 20/50 POSTOP DAY 1, DROPPED TO 20/200. WITH CORRECTION VISUAL ACUITY IS 20/30. NO OTHER INFORMATION WAS PROVED.
Patient problems: Blurred Vision; Therapeutic Effects, Unexpected
MAUDE report 10463676 ↗InjuryOct 24, 2019Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT A ZCT400 INTRAOCULAR LENS (IOL) WAS NOT LOADED PROPERLY AND THAT THE SURGEON HAD TO USE A SUTURE ON THE PRIMARY INCISION FOR CLOSURE SINCE THE RESURE SEALANT DID NOT WORK. REPORTEDLY, THE PATIENT TOLERATED THE PROCEDURE WELL AND THERE WERE NO COMPLICATIONS. NO FURTHER INFORMATION WAS PROVIDED.
Patient problems: No Code Available
MAUDE report 9233877 ↗InjuryJul 17, 2018Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
REPORTEDLY, A MALE PATIENT EXPERIENCED AN UNEXPECTED POST-OP REFRACTION IN HIS LEFT EYE (OS) AFTER IMPLANT OF A MODEL ZCT400 TORIC INTRAOCULAR LENS (IOL). PER ACCOUNT, THERE WAS A REFRACTIVE SURPRISE AND IT WAS DECIDED THAT THE ASTIGMATISM READINGS WERE INCORRECT DUE TO K SCANNING FROM SHINGLES AND THE BEST COURSE OF ACTION WAS TO REMOVE THE TORIC IOL AND REPLACE WITH A NON-TORIC IOL. THE LENS WAS EXPLANTED ON (B)(6) 2018. NO PATIENT INJURY AND NO INCISION ENLARGEMENT WERE REPORTED. THE PATIENT HAS RECOVERED. NO ADDITIONAL INFORMATION PROVIDED.
Patient problems: No Code Available
MAUDE report 7696394 ↗
Other LENS, INTRAOCULAR, TORIC OPTICS devices
- TECNIS IOL ZCT150Johnson & Johnson Surgical Vision, Inc. · LENS, INTRAOCULAR, TORIC OPTICS1 recall7 reports
- Clareon CNWTT0Alcon Laboratories, Inc. · LENS, INTRAOCULAR, TORIC OPTICS43 reports
- Clareon CNWTT0Alcon Laboratories, Inc. · LENS, INTRAOCULAR, TORIC OPTICS36 reports
- Clareon CNWTT0Alcon Laboratories, Inc. · LENS, INTRAOCULAR, TORIC OPTICS32 reports
- Clareon CNWTT0Alcon Laboratories, Inc. · LENS, INTRAOCULAR, TORIC OPTICS30 reports
- Clareon CNWTT0Alcon Laboratories, Inc. · LENS, INTRAOCULAR, TORIC OPTICS29 reports
- Clareon CNWTT0Alcon Laboratories, Inc. · LENS, INTRAOCULAR, TORIC OPTICS21 reports
- TECNIS IOL DIU150Johnson & Johnson Surgical Vision, Inc. · LENS, INTRAOCULAR, TORIC OPTICS19 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page